SARS-CoV-2 RBD Recombinant Human mAb (SDT-R005),specification,price,image-Bio-Equip in China

Product Detail
Company Profile

Product Specification

Host	Human
Antigen	SARS-CoV-2
Immunogen	Synthetic Peptide
Accession	P0DTC2
Clone Number	SDT-R005
Antibody Type	Human mAb
Application	ELISA
Reactivity	SARS-CoV-2
Cross Reactivity	Has cross-reactivity in ELISA with: SARS-CoV-2 (BA.2/Omicron) RBD, His Tag (S0A2003) SARS-CoV-2 (BA.2.12.1/Omicron) RBD, His Tag (S0A2015) SARS-CoV-2 (BA.4&BA.5/Omicron) RBD, His Tag (S0A2004) SARS-CoV-2 (BA.2.75/Omicron) RBD
Purification	Protein A
Concentration	4.0mg/ml
Conjugation	Unconjugated
Physical Appearance	Liquid
Storage Buffer	PBS, 40% Glycerol, 0.05%BSA, 0.03% Proclin 300
Stability & Storage	12 months from date of receipt / reconstitution, -20 °C as supplied

Dilution

application	dilution	species
ELISA	0.001-0.05μg/ml	null

Background

Sars-cov-2 (2019-NCOV) infects human respiratory epithelial cells through binding to human ACE2 receptors. Spike protein is a large type I transmembrane protein containing two subunits S1 and S2.S1 mainly contains a receptor binding domain (RBD), which is responsible for recognizing cell surface receptors. S2 contains the basic elements required for membrane fusion. S protein plays a key role in inducing neutralizing antibody and T cell responses as well as protective immunity.